Edition:
United States

Analysts: Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

5,262JPY
28 Apr 2016
Change (% chg)

¥-164 (-3.02%)
Prev Close
¥5,426
Open
¥5,497
Day's High
¥5,497
Day's Low
¥5,200
Volume
2,456,600
Avg. Vol
2,357,984
52-wk High
¥6,609
52-wk Low
¥4,950

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -51.44 March 29 Apr 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 10 9 9 10
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.75 2.73 2.73 2.75

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 1 439,600.00 439,600.00 439,600.00 --
Quarter Ending Dec-16 1 478,900.00 478,900.00 478,900.00 --
Year Ending Mar-16 13 1,830,800.00 1,840,000.00 1,820,460.00 1,801,230.00
Year Ending Mar-17 13 1,830,080.00 1,910,500.00 1,765,400.00 1,855,290.00
Earnings (per share)
Quarter Ending Mar-16 2 -51.44 -45.60 -57.28 --
Year Ending Mar-16 13 97.22 109.80 78.66 145.52
Year Ending Mar-17 13 154.68 234.23 122.60 174.02
LT Growth Rate (%) 1 10.31 10.31 10.31 10.97

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-15 478,700.00 489,208.00 10,508.00 2.20
Quarter Ending Sep-15 472,705.00 457,754.00 14,951.00 3.16
Quarter Ending Jun-15 443,050.00 446,295.00 3,245.00 0.73
Quarter Ending Mar-15 416,715.00 437,839.00 21,124.00 5.07
Quarter Ending Dec-14 458,674.00 488,633.00 29,959.00 6.53

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 439,600.00 439,600.00 444,200.00 444,200.00 --
Quarter Ending Dec-16 478,900.00 478,900.00 483,900.00 483,900.00 --
Year Ending Mar-16 1,830,800.00 1,830,800.00 1,830,280.00 1,831,860.00 1,801,230.00
Year Ending Mar-17 1,830,080.00 1,830,080.00 1,835,050.00 1,855,460.00 1,855,290.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 1
Quarter Ending Dec-16 0 0 0 1
Year Ending Mar-16 0 0 2 1
Year Ending Mar-17 0 0 1 2
Earnings

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$169.00
Provider : Wright Reports
$169.00
Provider : MarketLine
$50.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks